Skip to main content
TipRanks
Go Ultimate75% OFF

JEIL PHARMA HOLDINGS INC. (002620) Stock Statistics & Valuation Metrics

Total Valuation

JEIL PHARMA HOLDINGS INC. has a market cap or net worth of KRW 104.39B. The enterprise value is KRW 350.14B.

Market Cap
KRW 104.39B
Enterprise Value
KRW 350.14B

Share Statistics

JEIL PHARMA HOLDINGS INC. has 15,973,355 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
15,973,355
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

JEIL PHARMA HOLDINGS INC.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 1.88%.

Return on Equity (ROE)
0.05
Return on Assets (ROA)
0.02
Return on Invested Capital (ROIC)
1.88%
Return on Capital Employed (ROCE)
0.03
Revenue Per Employee
16.44B
Profits Per Employee
365.88M
Employee Count
40
Asset Turnover
0.75
Inventory Turnover
3.43

Valuation Ratios

The current PE Ratio of JEIL PHARMA HOLDINGS INC. is 12.37. JEIL PHARMA HOLDINGS INC.’s PEG ratio is 0.18.

PE Ratio
12.37
PS Ratio
0.17
PB Ratio
0.33
Price to FCF
-56.29
Price to Operating Cash Flow
8.80
PEG Ratio
0.18

Income Statement

In the last 12 months, JEIL PHARMA HOLDINGS INC. had revenue of 657.61B and earned 14.64B in profits. Earnings per share was 953.37.

Revenue
657.61B
Gross Profit
226.27B
Operating Income
15.07B
Pretax Income
39.55B
Net Income
14.64B
EBITDA
30.02B
Earnings Per Share (EPS)
953.37

Cash Flow

In the last 12 months, operating cash flow was 11.86B and capital expenditures -13.72B, giving a free cash flow of -1.85B billion.

Operating Cash Flow
11.86B
Free Cash Flow
-1.85B
Free Cash Flow per Share
-120.80

Dividends & Yields

JEIL PHARMA HOLDINGS INC. pays an annual dividend of ―, resulting in a dividend yield of 1.03%

Dividend Per Share
―
Dividend Yield
1.03%
Payout Ratio
N/A
Free Cash Flow Yield
-1.78%
Earnings Yield
8.08%

Stock Price Statistics

Beta
0.07
52-Week Price Change
-13.27%
50-Day Moving Average
7299.80
200-Day Moving Average
7749.75
Relative Strength Index (RSI)
42.05
Average Volume (3m)
4,653

Important Dates

JEIL PHARMA HOLDINGS INC. upcoming earnings date is Mar 17, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 17, 2027
Ex-Dividend Date
―

Financial Position

JEIL PHARMA HOLDINGS INC. as a current ratio of 1.16, with Debt / Equity ratio of 52.51%

Current Ratio
1.16
Quick Ratio
0.79
Debt to Market Cap
1.30
Net Debt to EBITDA
3.70
Interest Coverage Ratio
2.01

Taxes

In the past 12 months, JEIL PHARMA HOLDINGS INC. has paid 4.72B in taxes.

Income Tax
4.72B
Effective Tax Rate
0.12

Enterprise Valuation

JEIL PHARMA HOLDINGS INC. EV to EBITDA ratio is -5.77, with an EV/FCF ratio of -122.11.

EV to Sales
0.36
EV to EBITDA
-5.77
EV to Free Cash Flow
-122.11
EV to Operating Cash Flow
19.09

Balance Sheet

JEIL PHARMA HOLDINGS INC. has KRW 87.50B in cash and marketable securities with KRW 184.74B in debt, giving a net cash position of -KRW 97.23B billion.

Cash & Marketable Securities
KRW 87.50B
Total Debt
KRW 184.74B
Net Cash
-KRW 97.23B
Net Cash Per Share
-KRW 6,087.25
Tangible Book Value Per Share
KRW 29.66K

Margins

Gross margin is 39.48%, with operating margin of -0.67%, and net profit margin of 1.35%.

Gross Margin
39.48%
Operating Margin
-0.67%
Pretax Margin
3.96%
Net Profit Margin
1.35%
EBITDA Margin
-6.30%
EBIT Margin
2.03%

Analyst Forecast

The average price target for JEIL PHARMA HOLDINGS INC. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-10.88%
EPS Growth Forecast
―

Scores

Smart Score
―
AI Score
51